Astellas Pharma, Inc. (ALPMF)
12.90
0.00 (0.00%)
USD |
OTCM |
Dec 10, 16:00
Astellas Pharma Shareholders Equity (Quarterly): 10.92B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 48.28B |
| Nxera Pharma Co., Ltd. | 444.57M |
| PeptiDream Inc. | 356.14M |
| Stemcell Holdings, Inc. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.36B |
| Total Liabilities (Quarterly) | 12.44B |
| Debt to Equity Ratio | 0.4593 |
| Current Ratio | 1.033 |
| Net Debt Paydown Yield | 1.82% |